Tech Company Financing Transactions
Sware Funding Round
On 6/6/2024, Sware landed $6 million in Series B funding from First Analysis, Insight Venture Partners and LRVHealth.
Transaction Overview
Company Name
Announced On
6/6/2024
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Proceeds Purpose
he funding will be used to bolster research and development of Sware's computer systems validation (CSV) platform, Res_Q, to further streamline processes with artificial intelligence (AI), and to expand the company's sales team so it can bring the platform to more organizations struggling with validation debt, the unpaid cost of release, testing, GxP, and business requirements.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
214 Arlington Street
Chelsea, MA 02150
USA
Chelsea, MA 02150
USA
Phone
Undisclosed
Website
Email Address
Overview
At Sware, our mission is to rescue life sciences companies from the grip of validation debt; the unpaid cost of release, testing, GxP, and business requirements. Our Res_Q� platform offers the most complete validation solution available today. Res_Q eliminates validation debt and ensures peace of mind in an increasingly complex technology ecosystem.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/6/2024: Fizz venture capital transaction
Next: 6/7/2024: Dealt venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs